Research output per year
Research output per year
Personal profile
Research interests
Gastrointestinal cancer.
Clinical interests
General oncology, gastrointestinal cancer, GI, GU cancers, HIV related cancer, lymphomas
Fingerprint
Dive into the research topics where Benjamin Tan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolization
Kalaghchi, B., Ince, S., Barnes, J., Kiser, K., Chin, R. I., Mikell, J., Badiyan, S., Garcia, J., Zoberi, J., Doyle, M. B. M., Tan, B., Kim, S., Fraum, T. & Kim, H., 2024, In: Frontiers in Oncology. 14, 1433480.Research output: Contribution to journal › Article › peer-review
Open Access -
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
Oh, D. Y., He, A. R., Bouattour, M., Okusaka, T., Qin, S., Chen, L. T., Kitano, M., Lee, C. K., Kim, J. W., Chen, M. H., Suksombooncharoen, T., Ikeda, M., Lee, M. A., Chen, J. S., Potemski, P., Burris, H. A., Ostwal, V., Tanasanvimon, S., Morizane, C. & Zaucha, R. E. & 23 others, , Aug 2024, In: The Lancet Gastroenterology and Hepatology. 9, 8, p. 694-704 11 p.Research output: Contribution to journal › Article › peer-review
26 Scopus citations -
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA -Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
Nowak, J. A., Twombly, T., Ma, C., Shi, Q., Haruki, K., Fujiyoshi, K., Väyrynen, J., Zhao, M., Knight, J., Mane, S., Shergill, A., Kumar, P., Couture, F., Kuebler, P., Krishnamurthi, S., Tan, B., Philip, P., O'Reilly, E. M., Shields, A. F. & Ogino, S. & 2 others, , Aug 20 2024, In: Journal of Clinical Oncology. 42, 24, p. 2853-2859 7 p.Research output: Contribution to journal › Article › peer-review
-
Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B–Southwest Oncology Group 80702 (Alliance)
Brown, J. C., Ma, C., Shi, Q., Couture, F., Kuebler, P., Kumar, P., Tan, B., Krishnamurthi, S., Chang, V., Goldberg, R. M., O’Reilly, E. M., Shields, A. F. & Meyerhardt, J. A., Dec 1 2024, In: Journal of the National Cancer Institute. 116, 12, p. 2032-2039 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase II basket trial of Dual AntiCTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort
Patel, S. P., Othus, M., Chae, Y. K., Huynh, T., Tan, B., Kuzel, T., McLeod, C., Lopez, G., Chen, H. X., Sharon, E., Streicher, H., Ryan, C. W., Blanke, C. & Kurzrock, R., Jul 27 2024, In: Journal for ImmunoTherapy of Cancer. 12, 7, e009074.Research output: Contribution to journal › Article › peer-review
Open Access